{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:11:45Z","timestamp":1780107105000,"version":"3.54.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.diabres.2026.113150","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:44:50Z","timestamp":1770828290000},"page":"113150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exclusive association of non-HDL\/HDL ratio with albuminuria in diabetes and its nonlinear pattern in advanced CKD: Findings from NHANES 2015\u20132020"],"prefix":"10.1016","volume":"234","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4222-1712","authenticated-orcid":false,"given":"Xiaosu","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113150_b0005","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1016\/S2214-109X(23)00570-3","article-title":"An update on the global disparities in kidney disease burden and care across world countries and regions","volume":"12","author":"Bello","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.diabres.2026.113150_b0010","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.diabres.2026.113150_b0015","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/ndt\/gfae048","article-title":"Global health inequalities of chronic kidney disease: a meta-analysis","volume":"39","author":"Duff","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2026.113150_b0020","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfaf068","article-title":"Maintaining kidney health in aging societies: a JSN and ERA call to action","author":"Ortiz","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2026.113150_b0025","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","article-title":"Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2026.113150_b0030","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","author":"Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2026.113150_b0035","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2019.06.009","article-title":"Change in Albuminuria and GFR as end Points for Clinical Trials in Early Stages of CKD: a Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration with the US Food and Drug Administration and European Medicines Agency","volume":"75","author":"Levey","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2026.113150_b0040","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf123","article-title":"Impact of albuminuria screening in primary care on the detection and management of chronic kidney disease: findings from the ONDAAS study","volume":"18","author":"Sanchez-Ospina","year":"2025","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.diabres.2026.113150_b0045","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1136\/bmjgh-2017-000380","article-title":"Chronic kidney disease and the global NCDs agenda","volume":"2","author":"Neuen","year":"2017","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.diabres.2026.113150_b0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/jcm13010201","article-title":"Incretin Therapies for patients with Type 2 Diabetes and Chronic Kidney Disease","volume":"13","author":"Alicic","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.diabres.2026.113150_b0055","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel Prediction Equations for absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: a Scientific Statement from the American Heart Association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2026.113150_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1552219","article-title":"hs-CRP\/HDL-C can predict the risk of all cause mortality in cardiovascular-kidney-metabolic syndrome stage 1-4 patients","volume":"16","author":"Han","year":"2025","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.diabres.2026.113150_b0065","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41581-021-00423-5","article-title":"Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations","volume":"17","author":"Noels","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.diabres.2026.113150_b0070","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011162","article-title":"Association between Serum High-Density Lipoprotein Cholesterol Levels and Progression of Chronic Kidney Disease: results from the KNOW-CKD","volume":"8","author":"Nam","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.diabres.2026.113150_b0075","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.kint.2015.12.034","article-title":"Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression","volume":"89","author":"Bowe","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2026.113150_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-067731","article-title":"Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis","volume":"376","author":"Hodkinson","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2026.113150_b0085","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2217\/bmm-2022-0548","article-title":"Association of non-HDL-C-to-HDL-C ratio with coronary lesions and its prognostic performance in first-onset NSTEMI","volume":"17","author":"Mao","year":"2023","journal-title":"Biomark Med"},{"key":"10.1016\/j.diabres.2026.113150_b0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12944-015-0023-4","article-title":"The value of the apoB\/apoAIota ratio and the non-HDL-C\/HDL-C ratio in predicting carotid atherosclerosis among chinese individuals with metabolic syndrome: a cross-sectional study","volume":"14","author":"Qin","year":"2015","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.diabres.2026.113150_b0095","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2026.113150_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0325843","article-title":"Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and urinary albumin-creatinine ratio (ACR) in US adults: NHANES 2005-2018","volume":"20","author":"Yong","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2026.113150_b0105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2026.113150_b0110","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1172\/JCI118175","article-title":"Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. a potential mechanism for the accelerated vasculopathy of diabetes","volume":"96","author":"Schmidt","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2026.113150_b0115","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","article-title":"Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE","volume":"280","author":"Wautier","year":"2001","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"10.1016\/j.diabres.2026.113150_b0120","doi-asserted-by":"crossref","first-page":"E50","DOI":"10.1161\/01.RES.86.3.e50","article-title":"Regulation of endothelial nitric oxide synthase expression by albumin-derived advanced glycosylation end products","volume":"86","author":"Rojas","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.diabres.2026.113150_b0125","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1096\/fj.02-0490fje","article-title":"Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products","volume":"17","author":"Xu","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.diabres.2026.113150_b0130","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1006\/bbrc.2000.3685","article-title":"Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages","volume":"277","author":"Iwashima","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.diabres.2026.113150_b0135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrneph.2017.155","article-title":"Dyslipidaemia in nephrotic syndrome: mechanisms and treatment","volume":"14","author":"Agrawal","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.diabres.2026.113150_b0140","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/gfr454","article-title":"High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes","volume":"27","author":"Lopes-Virella","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2026.113150_b0145","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.3390\/ijms25105498","article-title":"Human In Vitro Oxidized Low-Density Lipoprotein (oxLDL) increases Urinary Albumin Excretion in Rats","volume":"25","author":"D\u0105bkowski","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113150_b0150","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2337\/diabetes.48.6.1331","article-title":"Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells","volume":"48","author":"Posch","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113150_b0155","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/000331970505600411","article-title":"Hyperglycemia, lipoprotein glycation, and vascular disease","volume":"56","author":"Veiraiah","year":"2005","journal-title":"Angiology"},{"key":"10.1016\/j.diabres.2026.113150_b0160","first-page":"127","article-title":"The Impact of the Blood Lipids Levels on Arterial Stiffness","volume":"10","author":"Baba","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"issue":"Suppl 2","key":"10.1016\/j.diabres.2026.113150_b0165","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.2337\/dcS15-3006","article-title":"SGLT2 Inhibitors and the Diabetic Kidney","volume":"39","author":"Fioretto","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2026.113150_b0170","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.3390\/ijms23084300","article-title":"Emerging evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL)","volume":"23","author":"Huang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.diabres.2026.113150_b0175","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.5551\/jat.4721","article-title":"Insulin suppresses HDL-mediated cholesterol efflux from macrophages through inhibition of neutral cholesteryl ester hydrolase and ATP-binding cassette transporter G1 expressions","volume":"17","author":"Yamashita","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.diabres.2026.113150_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155377","article-title":"ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease","volume":"139","author":"Zhang","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.diabres.2026.113150_b0185","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrneph.2009.184","article-title":"An update on the lipid nephrotoxicity hypothesis","volume":"5","author":"Ruan","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.diabres.2026.113150_b0190","doi-asserted-by":"crossref","first-page":"12749","DOI":"10.1038\/s41598-020-69794-2","article-title":"There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3-5","volume":"10","author":"Chiu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabres.2026.113150_b0195","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.48333","article-title":"Urinary Albumin-to-Creatinine Ratio in Normal Range, Cardiovascular Health, and All-Cause Mortality","volume":"6","author":"Mahemuti","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726000690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726000690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:45:15Z","timestamp":1780105515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726000690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":39,"alternative-id":["S0168822726000690"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113150","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exclusive association of non-HDL\/HDL ratio with albuminuria in diabetes and its nonlinear pattern in advanced CKD: Findings from NHANES 2015\u20132020","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113150"}}